Rosemary B. Duda, M.D. M.P.H.
Associate Professor, Department of Surgery, Harvard Medical School
Co-Director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center
Contact Info
Rosemary Duda
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: RW871 / Surgical Oncology
Phone: 617-667-2169
Fax: 617-667-2978
rduda@bidmc.harvard.edu
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: RW871 / Surgical Oncology
Phone: 617-667-2169
Fax: 617-667-2978
rduda@bidmc.harvard.edu
Assistant
Terri BrownBeth Israel Deaconess Medical Center
Research Abstract
Our laboratory research foucuses on evaluating the potential estrogenioity of commonly used herbal remedies. These studies are performed in estrogen sensitive and estrogen insensitive breast cancer cell lines. These studies include investigations on estrogen regulated gene induction, cell cycle analysis, growth proliferation studies and mechanism of action.Publications
- Duda RB, Zhong Y, Navas V, Li MZ, Toy BR, Alavarez JG.American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth.J Surg Oncol 1999 Dec;72(4):230-9.
10589039 - Duda RB, Taback B, Kessel B, Dooley DD, Yang H, Marchiori J, Slomovic BM, Alvarez JG.pS2 expression induced by American ginseng in MCF-7 breast cancer cells.Ann Surg Oncol 1996 Nov;3(6):515-20.
8915481




